Aurisco(SH:605116) Xin Lang Cai Jing·2025-10-09 08:00Core Viewpoint - The board of Aurite Pharmaceutical Co., Ltd. has approved a share repurchase plan to buy back shares through centralized bidding, with a budget of 60 million to 120 million yuan for the purpose of converting the company's convertible bonds [1] Summary by Relevant Sections - Repurchase Plan Details - The repurchase amount is set between 60 million and 120 million yuan, with a repurchase period of 12 months [1] - The upper limit for the repurchase price was originally not to exceed 25 yuan per share, adjusted to not exceed 24.71 yuan per share after equity distribution [1] - Current Repurchase Status - As of September 30, the company has repurchased a total of 1,746,738 shares, accounting for 0.43% of the total share capital [1] - The total funds paid for the repurchase amount to 35,607,509.68 yuan, with a repurchase price range between 18.83 and 22.59 yuan per share [1]